Thailand's Prime Minister, Abhisit Vejjajiva, has warned the USA that a downgrade of the Asian country's trade status would generate growing public pressure for more compulsory licenses to be issued against patent-protected drugs. The Bangkok Post reported that the Prime Minister gave the warning to a US delegation that included Ambassador Eric John and representatives of the US ASEAN Business Council.
The threat of trade sanctions against Thailand by the USA is the result of a series of compulsory licenses issued against research-based drugmakers under the World Trade Organization's agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs; Marketletters passim). Previous compounds that have been stripped of patent protection include:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze